共 213 条
[1]
Lazo M(2011)Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study BMJ 343 d6891-1846
[2]
Hernaez R(2010)Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology 52 1836-135
[3]
Bonekamp S(2013)Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges Hepatobiliary Pancreat Dis Int 12 125-185
[4]
Kamel IR(2012)Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 179-191
[5]
Brancati FL(2013)The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders Mediators Inflamm 2013 678627-173
[6]
Guallar E(2013)Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model Euro J Nutr 52 179-720
[7]
Clark JM(2013)Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury Nutr Diabetes 3 e81-436
[8]
Tilg H(2014)Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease Food Chem Toxicol 63 166-326
[9]
Moschen AR(2013)Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway Int Immunopharmacol 17 714-1454
[10]
Xiao J(2012)Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis Hepatology 55 429-2769